Loading…
Loading…
QUBT does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for QUBT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for QUBT and 80,000+ other tickers.
See exactly how QUBT's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for QUBT and 80,000+ other tickers.
Quantum Computing, Inc. (QUBT) is a Virginia-based technology firm dedicated to developing advanced software solutions for quantum computing. A cornerstone of their offerings is Qatalyst, a quantum application accelerator designed to empower developers. This platform allows users to design and execute 'quantum-ready' applications on conventional computing systems, ensuring seamless transition and compatibility with actual quantum hardware. Furthermore, QCI provides access to a variety of leading quantum processing units (QPUs), including D-Wave, Rigetti, and IonQ. The company primarily serves…
Next to the artificial intelligence infrastructure build-out, no trend is capturing the attention of investors quite like the evolution of quantum computing. Form 4 filings show that quantum computing insiders have been decisive sellers of their company's stock over the last half-decade.
Quantum Computing (NASDAQ: QUBT - Get Free Report)'s stock had its "buy" rating restated by stock analysts at Rosenblatt Securities in a research note issued to investors on Monday, Benzinga reports. They presently have a $22.00 target price on the stock. Rosenblatt Securities' price objective points to a potential upside of 237.68% from the company's previous
IBM is effectively funding its $10 billion, five‑year quantum push from its mainframe and software cash flows. IonQ is the only pure‑play quantum computing company with meaningful revenue, but it's still burning a lot of cash and issuing a lot of new shares.
Quantum Computing Inc. (NASDAQ: QUBT - Get Free Report) has been assigned an average recommendation of "Hold" from the seven analysts that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The
Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding the application of quantum computing to drug development BOCA RATON, Fla. and HOBOKEN, N.J.